Status:
COMPLETED
Cognitive Bias Modification for OCD
Lead Sponsor:
Mclean Hospital
Conditions:
Obsessive-Compulsive Disorder
Obsessive-compulsive Disorders and Symptoms
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will conduct the development and preliminary evaluation of Cognitive Bias Modification for Interpretation (CBM-I) and Approach Avoidance Training (AAT) as augmentations to treatment as usua...
Eligibility Criteria
Inclusion
- Currently receiving treatment at the McLean Hospital OCD Institute
- For CBM-I condition only: report a score of at least 131 on the Obsessive Beliefs Questionnaire-44 upon admission to the OCD Institute
- For AAT condition only: endorse score of at least 7 on the DOCS subscale #1 (contamination subscale) upon admission to the OCD Institute
- Able to complete a computer task for 20 minutes
- Consent to main OCD Institute study protocol
Exclusion
- Currently undergoing electroconvulsive therapy (ECT)
- Current symptoms of acute mania or psychosis
- A reported diagnosis at admission of a psychotic disorder
- History of traumatic brain injury
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 23 2024
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT03799419
Start Date
April 1 2019
End Date
July 23 2024
Last Update
July 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McLean Hospital
Belmont, Massachusetts, United States, 02478